Eikon Therapeutics Inc. Common Stock
EIKN | NASDAQ
$5.31
-$0.04 (-0.75%)
At close: Oct 30, 2026, 4:00 PM ET
$5.49
+$0.18 (+3.39%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 104.9M |
Short-Term Investments | 231.07M |
Long-Term Investments | n/a |
Other Long-Term Assets | 11.95M |
Receivables | n/a |
Inventory | n/a |
Other Current Assets | 12.94M |
Total Current Assets | 348.92M |
Property-Plant & Equipment | 233.86M |
Goodwill & Intangibles | n/a |
Total Long-Term Assets | 245.82M |
Total Assets | 594.73M |
Account Payables | 681K |
Deferred Revenue | n/a |
Short-Term Debt | n/a |
Other Current Liabilities | 35K |
Total Current Liabilities | 55.01M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 1.17B |
Total Long-Term Liabilities | 1.42B |
Total Liabilities | 1.47B |
Total Debt | 257.32M |
Book Value | -879.03M |
Book Value Per Share | -16.24 |
Common Stock | n/a |
Retained Earnings | -920.51M |
Comprehensive Income | n/a |
Shareholders Equity | -879.03M |
Total Investments | 231.07M |
Add to Watchlist
Select watchlists to add or remove EIKN